Revisiting Information Asymmetry: The role of ESG rating dispersion in inhibiting corporate innovation
The Singapore Economic Review · 04.11.2026
DOI: 10.1142/s0217590826500463 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Singapore Economic Review, online erschienen am 04.11.2026. Verfasst von Aamir Ali Gopang und 2 weiteren Autor:innen.
Abstract (Originalsprache)
This study examines the relationship between ESG rating dispersion and corporate innovation. Measured as differences in ESG scores across multiple rating agencies, ESG rating dispersion captures information inconsistency, rating noise, and firm-level complexity. Using Poisson, Negative Binomial, and pooled linear regression models, we find that higher ESG rating dispersion is associated with lower corporate innovation. Greater dispersion is also associated with higher information asymmetry, weaker ESG signaling, and increased uncertainty, which in turn link to financing constraints, reduced innovation willingness, and lower human capital deployment. Subsample analyses indicate these associations are more pronounced for firms with higher financial constraints and higher ESG ratings. The findings highlight the informational role of ESG rating dispersion and its relevance for understanding variation in corporate innovation.
Zitieren
APA
Gopang, A. A., Khalique, A., & Dossa, J. V. (2026). Revisiting Information Asymmetry: The role of ESG rating dispersion in inhibiting corporate innovation. The Singapore Economic Review. https://doi.org/10.1142/s0217590826500463
Vancouver
Gopang AA, Khalique A, Dossa JV. Revisiting Information Asymmetry: The role of ESG rating dispersion in inhibiting corporate innovation. The Singapore Economic Review. 2026. doi:10.1142/s0217590826500463
BibTeX
@article{Gopang2026,
author = {Gopang, Aamir Ali and Khalique, Abdul and Dossa, Joel Victor},
title = {Revisiting Information Asymmetry: The role of ESG rating dispersion in inhibiting corporate innovation},
journal = {The Singapore Economic Review},
year = {2026},
doi = {10.1142/s0217590826500463}
}
EUVIMED